The Issue: There is a back order of lidocaine 1% with epiNEPHrine 1:100 000 with preservative injection. Aspen Pharma is on back order with an unknown release date. The Pfizer brand product has an estimated release date of early March 2018.

Stock levels are very low and may not meet current demands. Inventory might be depleted prior to the resolution of this back order.

Key changes include:

Physicians should be aware of the shortage of lidocaine 1% with epiNEPHrine 1:100 000 with preservative injection.